UPDATED Mar 27, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$421.43 | -0.9% | 50.2% | US$3.1t | US$467.16 | PE37.9x | E12.6% | 0.7% | Software | ||
GOOGL | US$150.87 | 1.4% | 48.8% | US$1.9t | US$164.59 | PE25.4x | E11.8% | n/a | Media | ||
META | US$493.86 | -2.3% | 140.5% | US$1.3t | US$524.03 | PE32.2x | E14.3% | 0.4% | Media | ||
ADBE | US$504.40 | -2.8% | 33.0% | US$226.0b | US$617.38 | PE47.1x | E17.1% | n/a | Software | ||
NOVN | CHF86.66 | -0.07% | 4.0% | CHF189.8b | CHF98.16 | PE24.5x | E9.4% | 3.8% | Pharmaceuticals & Biotech | ||
ROG | CHF226.75 | 0.8% | -13.0% | CHF182.2b | CHF281.28 | PE15.7x | E8.3% | 4.2% | Pharmaceuticals & Biotech | ||
AXP | US$227.75 | -0.07% | 39.2% | US$164.0b | US$208.13 | PE19.9x | E8.9% | 1.2% | Diversified Financials | ||
PDD | US$116.66 | -11.7% | 60.1% | US$155.0b | US$180.97 | PE18.7x | E22.9% | n/a | Retail | ||
AIR | €171.60 | 1.4% | 40.4% | €135.1b | €172.40 | PE35.7x | E17.6% | 1.0% | Capital Goods | ||
VRTX | US$417.32 | 1.3% | 32.8% | US$107.8b | US$459.71 | PE29.8x | E11.2% | n/a | Pharmaceuticals & Biotech | ||
SAF | €209.35 | 1.3% | 52.9% | €86.6b | €200.21 | PE25.1x | E5.2% | 1.1% | Capital Goods | ||
CSL | AU$287.92 | 4.2% | 0.8% | AU$139.1b | AU$304.68 | PE36.5x | E15.2% | 1.3% | Pharmaceuticals & Biotech | ||
CRWD | US$322.25 | -1.4% | 148.6% | US$77.9b | US$390.31 | PE872.5x | E34.7% | n/a | Software | ||
1299 | HK$52.55 | -7.9% | -36.7% | HK$588.6b | HK$96.82 | PE20x | E17.5% | 3.1% | Insurance | ||
NTES | US$103.69 | -3.5% | 17.3% | US$64.8b | US$135.66 | PE15.9x | E8.1% | 2.5% | Media | ||
4568 | JP¥4,798.00 | -2.3% | 1.3% | JP¥9.2t | JP¥5,620.00 | PE49.4x | E23.9% | 1.3% | Pharmaceuticals & Biotech | ||
2454 | NT$1,160.00 | 1.8% | 49.1% | NT$1.8t | NT$1,190.76 | PE24x | E13.4% | 5.2% | Semiconductors | ||
600809 | CN¥245.10 | -1.9% | -10.9% | CN¥299.0b | CN¥289.47 | PE28.7x | E16.7% | 1.4% | Food, Beverage & Tobacco | ||
ALC | CHF75.22 | -0.6% | 15.8% | CHF37.1b | CHF84.21 | PE42.1x | E10.7% | 0.3% | Healthcare | ||
G | €23.67 | 2.2% | 29.4% | €37.3b | €22.80 | PE10.2x | E5.6% | 5.4% | Insurance | ||
RMD | US$196.33 | 2.1% | -8.1% | US$28.8b | US$204.98 | PE32.4x | E13.6% | 1.0% | Healthcare | ||
A068270 | ₩183,800.00 | -1.1% | 23.7% | ₩38.1t | ₩221,117.65 | PE71.1x | E35.1% | 0.3% | Pharmaceuticals & Biotech | ||
HWM | US$68.08 | 0.8% | 62.8% | US$27.9b | US$68.22 | PE36.6x | E14.6% | 0.3% | Capital Goods | ||
1024 | HK$49.05 | -4.3% | -17.4% | HK$212.8b | HK$77.17 | PE30.7x | E29.6% | n/a | Media |